
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the greatest impact for patients. Leveraging NGS-based and PCR-based technology to identify methylation changes, the Companys pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. The Companys non-invasive EpiCheck delivers highly accurate and sensitive results, all while providing a seamless testing option for physicians, patients, and the healthcare system. The Company is building an EpiCheck franchise, beginning with the Bladder EpiCheck kit, CE-marked and available in Europe for primary and recurrent bladder cancer and upper tract urinary...
Cancer diagnostics,detection,follow up,surveilance,urinary biomarkers,bladder cancer,lung cancer,methylation test,non muscle invasive bladder,and ngs
Nucleix ltd operates in the Biotechnology research industry.
Nucleix ltd's revenue is 11m - 100m
Nucleix ltd has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.